Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02680145 · ClinicalTrials.gov registry record · NA
Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use
A NA study of Pelvic Organ Prolapse and Uterine Prolapse, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 58
- Enrollment target
- 1
- Study location
NCT02680145 is a NA study of Pelvic Organ Prolapse and Uterine Prolapse that has completed, run by Mayo Clinic. The registered enrollment target is 58 participants, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02680145, a NA study of Pelvic Organ Prolapse and Uterine Prolapse, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 58 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single center, prospective trial of pessary use prior to reconstructive pelvic floor surgery for pelvic organ prolapse. The goal of the study is to evaluate the change in pelvic floor symptoms with pessary use and subsequent reconstructive surgery. Additionally, we will assess the impact that preoperative pessary use has on patient self-reported preparedness for surgery.
Conditions Studied
Interventions
- DEVICE Preoperative Pessary Use
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2016-03-11 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02680145
The ClinicalTrials.gov registry entry for NCT02680145 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 144-participant average among 40 other Pelvic Organ Prolapse trials with a reported enrollment target (60% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Pelvic Organ Prolapse appearing as the primary indexed condition, and to 1 intervention - of which Preoperative Pessary Use is the first listed.
NCT02680145 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT02680145 about?
NCT02680145 is a clinical study titled "Prediction of Postsurgical Symptomatic Outcomes With Preoperative Pessary Use". This is a single center, prospective trial of pessary use prior to reconstructive pelvic floor surgery for pelvic organ prolapse. The goal of the study is to evaluate the change in pelvic floor symptoms with pessary use and subsequent reconstructive surgery. Additionally, we will assess the impact t...
What is the current status of trial NCT02680145?
This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2016-03-11. Estimated completion is 2019-12-31.
What conditions does trial NCT02680145 study?
This clinical trial studies the following conditions: Pelvic Organ Prolapse, Uterine Prolapse, Vaginal Vault Prolapse, Pelvic Floor Prolapse.
What interventions are being tested in trial NCT02680145?
The interventions under investigation include: Preoperative Pessary Use (DEVICE).
Who is sponsoring clinical trial NCT02680145?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02680145 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Organ Prolapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
SORE Study: Sitz Baths After Urogynecologic Reconstruction
RECRUITING · NA
-
POMEGRANATE Trial: Comparing Reia Pessary Versus Standard of Care Pessary for Pelvic Organ Prolapse Treatment
RECRUITING · NA
-
Sequence of Midurethral Sling Placement During Robotic Sacrocolpopexy
RECRUITING · NA
-
The AccelERate Trial
RECRUITING · NA
-
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
ACTIVE NOT RECRUITING · NA
-
Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.